Generics Continuing its tirade against some developed and developing countries, the US drugmakers lobby group Pharmaceutical Research and Manufacturers of America (PhRMA) has urged the office of the US Trade Representative (USTR) to take immediate action to address serious market access and intellectual property (IP) barriers in 19 overseas markets, including India, reports The Pharma Letter’s India correspondent. 28 February 2018